Horae Gene Therapy Center
AAV Gene Therapy
AAVAA’s Key Collaborator:
Horae Gene Therapy Center & Horae Viral Vector Core
∙ The GTC is a world leader in AAV discovery, vector development, production, quality control testing and applications for pre-clinical gene therapy studies.
The Core comprises a > 3,000 square feet facility.
∙ The Vector Core has grown into a world class supplier of high-quality research grade viral vectors shipping to over 80 research entities worldwide with over $10M in revenue accrued for the FY2014-2019 period.
∙ Viral Vector Core creates and produce a variety of large quantity and high-quality viral vectors. Among those different viral vectors, rAAV is Viral Vector Core’s mainstream vector product with more than 1,500 lots produced per year.